Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
611.31B
Market cap611.31B
Price-Earnings ratio
29.36
Price-Earnings ratio29.36
Dividend yield
2.06%
Dividend yield2.06%
Average volume
10.72M
Average volume10.72M
High today
$254.21
High today$254.21
Low today
$251.08
Low today$251.08
Open price
$253.25
Open price$253.25
Volume
6.17M
Volume6.17M
52 Week high
$259.90
52 Week high$259.90
52 Week low
$152.81
52 Week low$152.81

Stock Snapshot

With a market cap of 611.31B, Johnson & Johnson(JNJ) trades at $253.06. The stock has a price-to-earnings ratio of 29.36 and currently yields dividends of 2.06%.

As of 2026-07-01, Johnson & Johnson(JNJ) stock has fluctuated between $251.08 and $254.21. The current price stands at $253.06, placing the stock +0.8% above today's low and -0.5% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 6.17M, compared to an average daily volume of 10.72M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $259.90 and a 52-week low of $152.81.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $259.90 and a 52-week low of $152.81.

JNJ News

Simply Wall St 2h
J&J Snack Foods Could Be 28% Undervalued Following Russell Index Rebalancing - simplywall.st

...

J&J Snack Foods Could Be 28% Undervalued Following Russell Index Rebalancing - simplywall.st
Simply Wall St 3h
Johnson & Johnson Reports IMAAVY Gains In Myasthenia Gravis And Pregnancy Study Plans

Johnson & Johnson reported new clinical data for IMAAVY (nipocalimab) in generalized myasthenia gravis, including sustained improvement in early stage and less...

Johnson & Johnson Reports IMAAVY Gains In Myasthenia Gravis And Pregnancy Study Plans
Nasdaq 10h
Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Key Points Bristol Myers Squibb focuses on specialized medicines in oncology and immunology, and shares sport a low valuation. Johnson & Johnson offers a dive...

Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

Analyst ratings

69%

of 26 ratings
Buy
69.2%
Hold
26.9%
Sell
3.8%

More JNJ News

24/7 Wall St. 10h
Here's How Much Money You Need to Replace a $50,000 Income With Dividends

Here’s How Much Money You Need to Replace a $50,000 Income With Dividends By Joel South Published Jul 1, 7:30AM EDT Quick Read ARCC's 11% yield needs just $47...

Here's How Much Money You Need to Replace a $50,000 Income With Dividends
Investor's Business Daily 1d
These Are The Best-Performing Dow Stocks Of Q2 And First Half Of 2026

Dow Jones Medical Giant J&J Breaks Out; PNC, Iron Mountain, Fortinet In Or Near Buy Zones 7:44 AM ET Dow Jones medical giant Johnson & Johnson are breaking out...

These Are The Best-Performing Dow Stocks Of Q2 And First Half Of 2026
Nasdaq 1d
If a Stock Market Crash Is Coming, History Shows This Stock Will Be a Brilliant Buy

Key Points This company tends to outperform the market during recessions. It has a highly resilient and reliable business and a rock-solid balance sheet. The...

If a Stock Market Crash Is Coming, History Shows This Stock Will Be a Brilliant Buy
Nasdaq 1d
Dow Analyst Moves: JNJ

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Johnson & Johnso...

Dow Analyst Moves: JNJ
Nasdaq 1d
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick

A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #8 broker pick, on average, out of the 30 stocks ma...

Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick
24/7 Wall St. 1d
Take Home an Electrician's Paycheck Without the High Voltage

Take Home an Electrician’s Paycheck Without the High Voltage By Drew Wood Published Jun 30, 10:38AM EDT Quick Read Replacing a $65,000 electrician salary with...

Take Home an Electrician's Paycheck Without the High Voltage
Simply Wall St 1d
Johnson & Johnson Could Be 31% Below Fair Value After Cancer Drug Progress

Johnson & Johnson (JNJ) is back in focus after the European Medicines Agency’s committee backed expanded use of its cancer drug Tecvayli with Darzalex, alongsid...

Johnson & Johnson Could Be 31% Below Fair Value After Cancer Drug Progress

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.